Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04797962 · ClinicalTrials.gov registry record · NA

Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder

A NA study, sponsored by Denver Health and Hospital Authority.

Completed
Registry status
NA
Development phase
102
Enrollment target

NCT04797962: Completed NA study, sponsored by Denver Health and Hospital Authority.

NCT04797962 is a NA study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04797962, a NA study, has completed, sponsored by Denver Health and Hospital Authority.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target

Study Summary

The overarching goal of the study is to develop, pilot, and evaluate an intervention that aims to retain patients who initiate buprenorphine at Denver Health in ongoing treatment for opioid use disorder.

Primary Outcome

Defined by proportion of participants retained in care at 90 days, as measured by the total number of intakes where patient has continued to be engaged in medication assisted treatment at 90 days from start of treatment divided by the total number of intakes where patients linked to follow up dosing or prescription, for each arm.

Interventions

  • BEHAVIORAL Case management

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2021-03-30
Est. Completion 2023-09-29
Phase NA

What the finished NCT04797962 record still lists

NCT04797962 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Case management is the first listed.

NCT04797962 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04797962 about?

NCT04797962 is a clinical study titled "Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder". The overarching goal of the study is to develop, pilot, and evaluate an intervention that aims to retain patients who initiate buprenorphine at Denver Health in ongoing treatment for opioid use disorder.

What is the current status of trial NCT04797962?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2021-03-30. Estimated completion is 2023-09-29.

What interventions are being tested in trial NCT04797962?

The interventions under investigation include: Case management (BEHAVIORAL).

Who is sponsoring clinical trial NCT04797962?

This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04797962's enrollment target sits among peer trials

102 837th of 2000 higher than 1,161 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03704662 · 102 participants · NA

    Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

  • NCT04174742 · 102 participants

    Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

  • NCT04275362 · 102 participants

    Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

  • NCT04541082 · 102 participants · Phase 1

    Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04797962, the US trial registry maintained by the National Library of Medicine. NCT04797962 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.